Even With The Health Law In Place, Costs Keep Going Up
The New York Times takes a look at the Geisinger Health Plan's efforts to provide care to the community it serves as a means to explore why health care expenses and insurance premiums continue to rise.
The New York Times:
Why Do Health Costs Keep Rising? These People Know
The Geisinger Health Plan, run by one of the nation’s top-rated health care organizations, foresees medical costs increasing next year by 7.5 percent for people buying insurance under the Affordable Care Act. So when Geisinger requested a rate increase of 40 percent for 2017, consumer advocates were amazed. And Kurt J. Wrobel, Geisinger’s chief actuary, found himself, along with other members of his profession, in the middle of the health care wars still raging in this political year. Actuaries normally toil far from the limelight, anonymous technicians stereotyped as dull and boring. But as they crunch the numbers for their Affordable Care Act business, their calculations are feeding a roaring national debate over insurance premiums, widely used to gauge the success of President Obama’s health care law. (Pear, 6/9)
In other national health care news —
The New York Times:
Delay Pregnancy In Areas With Zika, W.H.O. Suggests
People living in areas where the Zika virus is circulating should consider delaying pregnancy to avoid having babies with birth defects, the World Health Organization has concluded. The advice affects millions of couples in 46 countries across Latin America and the Caribbean where Zika transmission is occurring or expected. According to a recent study, more than five million babies are born each year in parts of the Western Hemisphere where the mosquitoes known to spread the virus are found. (McNeil, 6/9)
The Associated Press:
Investigator: FDA Still Taking Months To Recall Tainted Food
Federal health officials failed to force a recall of peanut butter and almond products for three months after advanced DNA testing confirmed salmonella contamination, government investigators reported Thursday. Despite new legal powers to compel recalls and sophisticated technology to fingerprint pathogens, the Food and Drug Administration allowed some food-safety investigations to drag on, placing consumers in jeopardy of death or serious illness, according to the inspector general's office at the Department of Health and Human Services. (6/9)
Reuters:
FDA Seeks Suspension of 4,402 Illegal Prescription Drug Websites
The U.S. Food and Drug Administration said on Thursday it, along with international authorities, has formally sought to suspend 4,402 websites that illegally sell potentially dangerous, counterfeit or unapproved prescription drugs to U.S. consumers. The move is part of a global effort being led by the INTERPOL, the world's largest police organization, to identify the makers and distributors of illegal prescription drugs. (Grover, 6/9)